| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin's lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial.
|
J Clin Oncol
|
2009
|
1.54
|
|
2
|
Cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab versus epirubicin, cyclophosphamide, vinblastine, prednisone and rituximab for the initial treatment of elderly "fit" patients with diffuse large B-cell lymphoma: results from the ANZINTER3 trial of the Intergruppo Italiano Linfomi.
|
Leuk Lymphoma
|
2011
|
1.53
|
|
3
|
Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients.
|
Br J Haematol
|
2005
|
1.45
|
|
4
|
Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia.
|
Blood
|
2010
|
1.34
|
|
5
|
Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocol.
|
Blood
|
2005
|
1.24
|
|
6
|
Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: an Italian multicenter randomized trial.
|
J Clin Oncol
|
2003
|
1.09
|
|
7
|
Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study.
|
Ann Hematol
|
2012
|
1.02
|
|
8
|
Incidence of bacterial and fungal infections in newly diagnosed acute myeloid leukaemia patients younger than 65 yr treated with induction regimens including fludarabine: retrospective analysis of 224 cases.
|
Eur J Haematol
|
2008
|
0.91
|
|
9
|
Lenograstim reduces the incidence of febrile episodes, when compared with filgrastim, in multiple myeloma patients undergoing stem cell mobilization.
|
Leuk Res
|
2010
|
0.88
|
|
10
|
Phase II fludarabine and cyclophosphamide for the treatment of indolent B cell non-follicular lymphomas: final results of the LL02 trial of the Gruppo Italiano per lo Studio dei Linfomi (GISL).
|
Ann Hematol
|
2010
|
0.87
|
|
11
|
Amphotericin B lipid complex in the management of invasive fungal infections in immunocompromised patients.
|
Clin Drug Investig
|
2011
|
0.81
|
|
12
|
A simple prognostic scoring system for newly diagnosed cytogenetically normal acute myeloid leukemia: retrospective analysis of 530 patients.
|
Leuk Lymphoma
|
2011
|
0.78
|
|
13
|
Case-control study of multidrug resistance phenotype and response to induction treatment including or not fludarabine in newly diagnosed acute myeloid leukaemia patients.
|
Br J Haematol
|
2007
|
0.77
|